Rapid Therapeutic Science Laboratories Inc. (RTSL)
OTC PINK OTC PINK Primary Summary
Rapid Therapeutic Science Laboratories Inc. (RTSL) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Rapid Therapeutic Science Laboratories Inc. ever had a stock split?
Rapid Therapeutic Science Laboratories Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Donal R. Schmidt Jr. CEO | OTC PINK Exchange | 753431204 CUSIP |
| US Country | 3 Employees | - Last Dividend | 31 Mar 2022 Last Split | - IPO Date |
Overview
Rapid Therapeutic Science Laboratories, Inc. is a biotech company that centers its efforts on the innovative use of non-psychoactive cannabinoids for therapeutic purposes. Geared towards addressing a range of conditions such as chronic pain, post-traumatic stress disorder (PTSD), insomnia, and recovery from surgery, the company capitalizes on the aerosol delivery method to expedite cannabinoids' absorption into the bloodstream. Originally known as Holly Brothers Pictures, Inc., the company underwent a rebranding to its current identity in January 2020. Having been established in 2013 and located in Dallas, Texas, Rapid Therapeutic Science Laboratories showcases a journey from its origins to becoming an influential entity in the realm of cannabinoid research and therapeutics. Previously, it operated as a subsidiary of Texas Mdi, Inc., marking its evolution within the biotech industry.
Products and Services
The product portfolio of Rapid Therapeutic Science Laboratories, Inc. is distinguished by its focus on delivering innovative and effective cannabinoid-based therapeutics. Below is a detailed exploration of their primary offerings:
- Pressurized Meter Dose Inhaler: This device is central to the company's product line, designed to deliver a calculated amount of aerosolized medication directly to the lungs. It represents a hallmark in their method of leveraging aerosol delivery systems for rapid and efficient cannabinoid administration, targeting ailments like chronic pain and PTSD.
- Sublingual Oral Spray Devices: These devices cater to individuals seeking a discreet and convenient method of cannabinoid consumption. The sublingual oral spray ensures swift absorption through the mucous membranes, offering an alternative to inhalation for users preferring or needing different administration routes.
- Water-Soluble Cannabidiol (CBD) and Cannabigerol (CBG) Isolates: Under the nhaler brand, the company furnishes isolates of CBD and CBG in water-soluble form. This innovation underscores the company's commitment to providing versatile and user-friendly products, broadening the usage spectrum of cannabinoids for therapeutic effects.
